Litcius/Paper detail

Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors

Francesco Locatelli, Roberto Minutolo, Luca De Nicola, Lucia Del Vecchio

2022Drugs45 citationsDOIOpen Access PDF

Topics & Concepts

MedicineKidney diseasePharmacotherapyPharmacologyInternal medicineIntensive care medicineErythropoietin and Anemia TreatmentBlood transfusion and managementCancer, Hypoxia, and Metabolism
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors | Litcius